issued
on 20 Aug 2024
Last Applicant/ Owned by
2 Tower Place
San Francisco
CA
94080
Serial Number
97444581 filed on 06th Jun 2022
Registration Number
N/A
Correspondent Address
Jessica L. Rothstein
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
research and development of pharmaceuticals; research and development of pharmaceutical preparations for use in immunology therapy New product commercialization services, namely, commercialization of pharmaceutical preparations and commercialization of pharmaceutical preparations for use in immunology therapy pharmaceutical preparations for use in immunology therapy Custom manufacture of pharma Read More
research and development of pharmaceuticals; research and development of pharmaceutical preparations for use in immunology therapy
N/A
N/A
New product commercialization services, namely, commercialization of pharmaceutical preparations and commercialization of pharmaceutical preparations for use in immunology therapy
N/A
N/A
pharmaceutical preparations for use in immunology therapy
N/A
N/A
Custom manufacture of pharmaceuticals and pharmaceuticals for use in immunology therapy
N/A
N/A
No 97444581
No Service Mark
No 146565325532
No
No
No
No
No
No
No
No
26.11.21 -
Rectangles that are completely or partially shaded
26.11.28 -
Miscellaneous designs with overall rectangular shape
26.17.12 -
Chevrons and angles
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Status Date | Action Taken |
---|---|
20th Aug 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
25th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
25th Jun 2024 | PUBLISHED FOR OPPOSITION |
05th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
22nd May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
07th Feb 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
07th Feb 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
05th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
13th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
13th Nov 2023 | NON-FINAL ACTION E-MAILED |